73526-82-6

Upstream product

• 1007-26-7 (2,2-dimethyl-1-propyl)benzene 
• 26110-96-3 1-(2,2-dimethylpropyl)-4-nitrobenzene 
• 865471-98-3 1-(2,2-dimethyl-propyl)-2-nitro-benzene 

Downstream Products

• 97528-14-8 o-Neopentyl-acetanilid 
• 16670-59-0 2-neopentylphenol 
• 20836-11-7 2,3-dihydro-2,2-dimethyl-1H-indene 

Relevant academic research and scientific papers

SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

METHODS OF TREATMENT OF AMYLOIDOSIS USING BI-CYCLIC ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INHIBITORS

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.